08
Jun
Jun
Semaglutide, a GLP-1 receptor agonist marketed under brand names such as Ozempic and Wegovy, is primarily used for managing type 2 diabetes and aiding weight loss. Concerns about its potential impact on kidney health have been a topic of interest. Here’s a detailed look at the current understanding based on recent research: Protective Effects on […]